Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive    source : Ir.zynerba.com    save search
Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit
Published: 2022-10-17 (Crawled : 12:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
 | | O: 0.35% H: 3.49% C: 3.49%
rare pharmaceuticals inspire trial positive
Gainers vs Losers
89% 11%

Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance
EDBL | News | $6.94 84.57% 1.4M twitter stocktwits trandingview |

CZOO | $8.77 75.75% 11M twitter stocktwits trandingview |

VNRX | $0.84 40.0% 2.6M twitter stocktwits trandingview |
Health Technology
OPRT | News | $3.01 33.78% 6.8M twitter stocktwits trandingview |
Finance
MLEC | $1.81 29.29% 2M twitter stocktwits trandingview |
n/a
CMAX | $4.12 28.35% 65K twitter stocktwits trandingview |
Manufacturing
MTC | $2.0 28.21% 1.7M twitter stocktwits trandingview |
Technology Services
PEGY | $0.0586 27.95% 130M twitter stocktwits trandingview |
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.